Company ProfilePremium

Integra Life Sciences

Company Profile Analysis

ESOMAR 23 Corporate BadgeISO Certifications Badge
Integra Life Sciences - Healthcare showcase

Year Founded & Workforce

1989

4,700 Employees

Industry

Healthcare

Services

Biopsy Device
I

Integra Life Sciences Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

Integra Life Sciences Overview

Company Headquarters: US

Founded: 1989

Workforce: 4,700

Company Working: Integra Life Sciences is a leading global medical technology company that specializes in developing, manufacturing, and marketing innovative products and solutions to meet the needs of surgeons, healthcare professionals, and patients worldwide. Integra products are sold in over 130 countries via a direct sales force, distributors, and wholesalers. Codman Specialty Surgical ("CSS") and Tissue Technologies ("TT") are the two reportable business segments in which company manufacture and sell medical technologies and products. The CSS segment, which accounts for two-thirds of our total revenue, consists of market-leading technologies and instrumentation used in a variety of specialties, including neurosurgery, neurocritical care, and otolaryngology.

Strategy

Integra is dedicated to providing high-quality products that improve the lives of millions of patients and their families. The company’s strategy is built four key pillars: enabling an execution-focused culture, optimizing relevant scale, advancing innovation and agility, and providing a superior customer experience. The company believe that by focusing more on these areas through better planning and communication, infrastructure optimization, and strategically aligned acquisitions, they can build scale, increase competitiveness, and achieve our long-term goals.

Company Snapshot

$1,517.6M

Revenue

4,700

Employees

1989

Founded

US

Headquarters

SWOT Analysis

Strengths

  • Focus on innovation and product development to meet the changing needs of healthcare professionals and patients
  • Strong brand reputation for quality and reliability

Weaknesses

  • Limited penetration in emerging markets

Opportunities

  • Potential for partnerships and collaborations to expand product offerings and market reach

Threats

  • Increasing regulation and scrutiny of medical devices and technologies

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Product Offering

  • Integra Life Sciences
    • Biopsy Device

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

By Business Segment: Sales rose from USD 1,517.6 Mn in 2019 to USD 1,542.4 Mn in 2021.
Integra Life Sciences — By Business Segment
Series (USD Mn)201920202021
Sales1,517.61,371.91,542.4
R&D Expenditure79.677.493.1

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.